Clinical-grade AI that retrieves, reasons, and delivers structured intelligence across imaging, genomics, pathology, and clinical documentation.
Modern medicine requires simultaneous reasoning across disparate data types. AXIVIS is built to ingest and correlate the full clinical spectrum.
Medical knowledge doubles every 73 days. No clinician can read it all. AXIVIS Medical Intelligence retrieves structured evidence from verified clinical literature at the point of care, and reasons across imaging, laboratory, genomic, and clinical data simultaneously through AXIVIS Cortex.
Imaging interpreted without laboratory context. Laboratory results reviewed without imaging correlation. Procedural findings documented separately from genomic data. AXIVIS applies dedicated intelligence models to every diagnostic data type and surfaces findings within a single clinical environment.
Tumor imaging. Genomic mutations. Biomarker progression. Treatment history. Trial eligibility. Multidisciplinary decisions. AXIVIS consolidates these data streams into a single continuous intelligence model across the full cancer care pathway.
Physicians spend more time on records, orders, and administrative tasks than on patients. AXIVIS Clinical Infrastructure is the operational layer built to change that ratio.
The intelligence layer underlying AXIVIS processes medical imaging, genomic data, laboratory results, electronic health records, and clinical documentation. Reasoning built for the data types that define modern clinical practice.
AXIVIS Black ingests your laboratory results, genetic data, imaging reports, and health records. AI analyzes them structurally, identifies risk patterns, tracks biological markers over time, and surfaces what requires attention. Not summaries. Not scores. Clinical-grade intelligence applied to your own data.
Medical knowledge relevant to a clinical decision exists in published literature, clinical guidelines, drug safety databases, and the patient's own history simultaneously. Accessing all of it manually, during a consultation, while managing the patient in front of you, is not possible.
AXIVIS processes natural language medical queries against verified clinical literature, research publications, drug safety databases, and medical guidelines. The system retrieves relevant evidence, synthesizes it into a structured response, and presents citations linking to the original sources. Drug safety profiles, biomarker data, diagnostic considerations, and clinical research findings are all accessible through a single query. Voice input is supported. No literature search training required. No leaving the clinical workflow.
A clinician encounters a rare drug interaction during a consultation. They submit a natural language query. AXIVIS retrieves relevant evidence from clinical literature, synthesizes a structured summary, and presents citations to the original sources. The answer is available before the consultation ends.
Clinical decision making rarely involves a single data type. A physician evaluating a complex patient is looking at imaging findings, laboratory results, genomic data, and clinical documentation simultaneously. AXIVIS Cortex processes all of these inputs together through a conversational interface. DICOM imaging studies, laboratory results, genomic data, and clinical documents are analyzed in combination. The system identifies relevant diagnostic considerations, suggests follow-up investigations, and generates structured analytical responses that reflect the complete patient picture. Not a single data point in isolation.
A physician uploads a CT chest, a recent full blood count, and a genomic panel for a patient with an unresolved pulmonary finding. AXIVIS Cortex analyzes all three together, identifies a pattern consistent with an inflammatory process, surfaces relevant diagnostic considerations, and suggests two follow-up investigations. The physician reviews and proceeds.
Retrieves and synthesizes knowledge from external medical literature. The input is a clinical question. The output is structured evidence from published sources with citations.
Used when a clinician needs to know what the literature says about a drug, a condition, a biomarker, or a clinical scenario.
Reasons across the patient's own clinical data. The input is imaging, laboratory results, genomic reports, and clinical documents. The output is structured analytical reasoning about that specific patient's data.
Used when a clinician needs to understand what the patient's data means, not what the literature says in general.
Evidence retrieval and multimodal patient data analysis supporting clinical decision making across specialties, from general practice through complex specialist care.
Structured analytical support for interpreting complex combinations of imaging, laboratory, and genomic data within the diagnostic workflow.
Access to synthesized clinical literature, drug safety profiles, biomarker data, and research findings relevant to patient care and clinical research activities.
Clinical Intelligence Search surfaces evidence relevant to diagnostic findings generated in Diagnostic Intelligence. AXIVIS Cortex reasons across imaging data from Radiology AI, laboratory trends from Labs & Screening, and genomic results from Genomic Intelligence. The knowledge layer connects to every domain.
An oncologist managing a single advanced cancer patient may review data from imaging, pathology, genomics, laboratory markers, and treatment records across multiple systems, teams, and time points. None of these systems were designed to talk to each other. The oncologist is the integration layer.
Oncology Intelligence is deployed in active oncology departments today. The views below are from a live institutional instance — patient identifiers retained for illustration, interface unchanged. Every panel, status chip, and decision surface shown is the shipping product.
Every active patient is rendered as a clinical record card. Tumor type is tagged at the left (THORAC, MCRC, MEDIAS, PEMBRO). Status chips on the right indicate criticality (CRITICAL · URGENT · REVIEW), treatment cadence (ROUTINE · SCHEDULED), stage, and ECOG performance score. Active protocol and cycle are bound directly to each patient — Encorafenib 300mg OD + Cetuximab 500mg/m² Q2W, Cycle 4, Next: HOLD.
Toxicity events surface inline as grade-tagged chips: G4 Neutropaenia, G2 Hepatotoxicity, G2 Anaemia — aligned to CTCAE grading and routed into the department's tox-flag counters.
Radiology is not a list of reports. It is a continuous longitudinal model of disease. A patient-level anatomical canvas renders every tracked lesion in anatomical position, colour-coded by RECIST response (Responding, Stable, Progressing). Hovering any organ reveals site-specific findings — in this view, Small Intestine returns No findings; other regions surface lesion counts, SLD contribution, and prior-scan deltas.
Four department-grade KPIs frame the view: Disease Status (Awaiting Data · Responding · Stable · Progressing), Tumor Burden vs Baseline, Tracked Lesions with target / non-target split, and Reports Reviewed. Distribution filters segment the view across Organs · Lymph Nodes · Skeletal · Skin · Systemic.
Oncology orders span modalities. A thoracic MDT referral for a suspected NSCLC, an Encorafenib/Cetuximab cycle review, an RT planning session for mediastinal lymphadenopathy, and a pembrolizumab maintenance cycle all flow through the same structured queue — each tagged by type (MDT · CHEMO · RT · IMMUNO), priority (URGENT · ROUTINE), and status (PENDING · REVIEW · SCHEDULED).
Selecting an order opens a structured detail panel on the right: Order ID, placing clinician, department, placed timestamp, due date, and clinical indication. Take Order · Schedule · Assign · Upload · Reject are the five institutional actions — every one logged, every one attributed.
The Oncology Performance Dashboard surfaces the five indicators that determine whether a cancer service is running to standard: Active Cases, AI Accuracy with override rate, Protocol Adherence against ESMO / NICE guidelines, Tox Flags with grade threshold, and Critical Actions requiring immediate review.
Weekly Case Throughput is segmented by treatment type (CHEMO · IMMUNO · MDT · RT). Treatment Response Distribution reports the full spread — CR · PR · SD · PD · NE — with a single institutional Disease Control Rate at the bottom. Oncologist Workload lists every attending with online status, active caseload, critical cases, tox alerts, and workload tier.
AXIVIS tracks tumor measurements across imaging studies using standardized oncology response assessment criteria. Baseline measurements are established at diagnosis. Every subsequent imaging study is compared against baseline. Change calculations, progression indicators, and response classifications are generated automatically and linked to the patient's longitudinal record. The oncologist reviews trends, not individual scans in isolation.
A follow-up CT is uploaded. AXIVIS compares it against the baseline and three prior studies, calculates change from prior, and response classification are ready before the radiologist begins manual review.
Standardized oncology response assessment frameworks applied automatically across treatment cycles.
Every lesion tracked across every imaging study. Change calculations and progression trends visible in a single view.
Genomic findings are among the most complex data types in cancer care. AXIVIS ingests sequencing reports and VCF files, annotates variants for clinical significance, identifies pathogenic mutations relevant to treatment selection, and surfaces pharmacogenomic considerations that affect how the patient will respond to specific therapies. The oncologist receives a structured, prioritized genomic summary. Not a raw variant list.
Every identified variant classified by clinical significance and annotated with supporting literature references.
Variants affecting drug metabolism and treatment response identified and linked to current medication and treatment plans.
Blood-based biomarkers are among the earliest indicators of treatment response and disease recurrence. AXIVIS records tumor marker measurements, generates longitudinal trend visualizations, and surfaces changes that may reflect disease activity or treatment efficacy. Reference ranges and trend indicators are displayed alongside historical values. The oncologist sees the trajectory, not just the latest number.
Biomarker values plotted across the full treatment timeline. Change from prior visible at a glance.
Rising biomarker trends flagged against established reference ranges and prior treatment response patterns.
Biomarker trends correlated with tumor measurement data from the same treatment timeline.
Cancer treatment involves multiple modalities, multiple cycles, and multiple decision points. AXIVIS documents treatment regimens across chemotherapy, immunotherapy, targeted therapy, radiation, and surgical interventions. Treatment timelines are visualized across the care pathway. Status is updated as therapy progresses. The complete treatment history is available in the same environment as imaging findings, genomic data, and biomarker trends.
Chemotherapy, immunotherapy, targeted therapy, radiation, and surgical records in one timeline.
Individual treatment cycles documented with status, dates, and clinical notes at each stage.
Treatment response correlated with tumor measurements and biomarker progression across the same timeline.
Clinical trial eligibility is determined by a combination of cancer type, stage, genomic profile, treatment history, and demographic factors. Manually reviewing trial eligibility for every patient against every available study is not feasible in a high-volume oncology practice. AXIVIS evaluates the patient's clinical and molecular profile against available trials and surfaces potential matches for oncologist review. The oncologist makes the eligibility determination. AXIVIS ensures no trial is missed because the data was never compared.
A patient with refractory non-small cell lung cancer has an EGFR exon 20 insertion identified on genomic analysis. AXIVIS surfaces three trials with eligibility criteria that match the patient's molecular profile and treatment history.
Trial matches based on genomic variants, cancer type, stage, treatment history, and demographic eligibility factors.
Matching is presented as informational support. Eligibility confirmation and enrollment remain with the clinical team.
Cancer care decisions involving multiple specialties require a shared record of what was discussed, who participated, and what was recommended. AXIVIS provides structured documentation for multidisciplinary tumor board meetings including participating specialists, clinical data reviewed, and consensus recommendations. Surveillance activities scheduled after treatment are tracked against the patient record. Follow-up tasks are visible to the care team. Nothing is left to informal communication.
Meeting details, participating specialists, data reviewed, and consensus recommendations recorded and linked to the patient record.
Post-treatment follow-up activities scheduled, tracked, and flagged when overdue against the patient's care timeline.
Every member of the oncology care team sees the same patient record, the same treatment history, the same open tasks.
Medical, surgical, and radiation oncologists and their nursing teams managing the full cancer care pathway from diagnosis through long-term surveillance.
Institutional oncology programs requiring structured documentation, multidisciplinary coordination, and integrated data management across the care team.
Clinical genetics specialists and precision medicine teams translating complex genomic and molecular data into actionable treatment decisions.
Deep learning analysis of endoscopic, surgical, and interventional procedural video. Frame-by-frame detection of polyps, mucosal abnormalities, bleeding sites, and anatomical landmarks. Structured procedural reporting with complication tracking across the full intervention lifecycle.
Procedure Intelligence is deployed in active endoscopy, bronchoscopy, and gynaecology suites today. The following walks the full cycle — departmental worklist, per-finding report drill-down, and serial procedure comparison — all from a live institutional instance. Patient identifiers retained for institutional realism; interface unchanged.
The worklist opens to the full departmental procedureFindings queue. Six KPIs anchor the view: Procedures Today, Critical/STAT, Awaiting Review, AI Accuracy with flag PPV, Avg TAT with manual baseline, and Types Active across the procedural domains in flight. Today's queue shows four active procedureFindings across three domains — two endoscopy, one bronchoscopy, one gynaecology.
Every row carries the full institutional procedural ledger: Order No (PO-2026-xxxxx) with corresponding procedure accession (PROC-xxxxx), priority chip (URGENT · ROUTINE · STAT), patient identity with MRN and age, procedure type chip with test composition, AI-extracted preliminary finding with confidence score, status chip, scientist attribution, timestamp, and View Report · View Results actions.
Selecting any row from the worklist opens the corresponding procedural report. The report carries the full patient chrome bar, a seven-tab navigation surface, and an AI SCORE badge at the top right — in this case 82% · REVIEW for Sarah Mitchell's urgent gastroscopy. Two institutional actions at the top of every report: + Addendum and Sign Report.
The Key Findings tab renders every finding as a structured card — procedural title, interval-change chip (STABLE · WORSENING · IMPROVING · NEW), severity status (REVIEW · NORMAL · CRITICAL), proc type, ICD-10 code, clinical description in the specialist vocabulary, AI confidence bar, and a dense PRIOR → CURRENT comparison row.
First card: Irregular Z-line — Suspected Barrett's Oesophagus · STABLE · REVIEW · Proc Type ENDO · ICD-10 K22.7 · 84% confidence. Description: "Irregular Z-line at 38cm from incisors. Salmon-coloured mucosa extending 2–3cm circumferentially proximal to GEJ. Prague classification C2M3. Three targeted biopsies taken. No dysplasia seen macroscopically." Prior: "C1M2 — biopsies negative for IM". Current: "C2M3 — biopsies pending".
Second card: Hiatus Hernia · STABLE · NORMAL · ENDO · ICD-10 K44.9 · 96% confidence. Description: "Sliding hiatus hernia approximately 3cm. GEJ at 38cm, diaphragmatic impression at 41cm. No strangulation or obstruction identified." Prior: "2cm hiatus hernia". Current: "3cm hiatus hernia".
The Prior Procedure tab renders the full surveillance arc for this patient. A PROCEDURE TIMELINE anchors the view with the prior procedure on the left and the current procedure on the right, separated by the interval elapsed — in this patient's case, 2.0 years (748 days).
Below the timeline, a PRIOR PROCEDURE vs CURRENT PROCEDURE comparison renders the structured ledger for both procedures side-by-side — Date, Operator, Instrument, and AI disposition. Then the FINDING COMPARISON ledger: every finding from both procedures aligned with a stability chip, interval-change text, and confidence bar. Finally, PRIOR IMPRESSION vs CURRENT IMPRESSION side-by-side prose — the reporting clinician sees both reports in the same frame, with two years of elapsed surveillance in between.
The same two-procedure timeline from the product is reconstructed below in the page — an active interval-flow showing the two years of surveillance elapsed between prior gastroscopy and current gastroscopy for this patient, with Prior vs Current procedure cards, finding comparison ledger, and impression diff rendered live.
The Pending Procedures surface handles the full procedural order lifecycle — from clinician request through consent, pre-procedural optimisation, list scheduling, and theatre assignment. Three pending orders active on the current session:
The Analytics surface renders the quality indicators that determine whether a procedural service is running to standard — throughput, turnaround, detection, quality, and clinician workload. Six quality indicators anchor the procedural governance ledger:
Each procedure type processed by dedicated deep learning models trained on annotated procedural video datasets.
Procedural video is ingested as MP4/MOV and processed frame-by-frame through modality-specific convolutional neural networks. The system identifies anatomical landmarks, detects abnormalities in real time, characterises findings by morphology and location, and generates timestamped annotations throughout the procedure. Unlike static imaging, procedural video requires continuous temporal analysis — a finding visible for 0.3 seconds during withdrawal is as clinically significant as one visible for 30 seconds.
Each frame analysed independently and correlated temporally. Findings tracked across sequential frames to distinguish transient artefacts from persistent abnormalities.
Detected polyps classified by Paris morphology (0-Ip, 0-Is, 0-IIa, 0-IIb, 0-IIc, 0-III), Kudo pit pattern analysis, and AI-estimated size. Each detection includes confidence score and anatomical segment location.
Beyond polyps, the system detects mucosal inflammation, erosive changes, ulceration, abnormal vascular patterns, and early neoplastic changes across the assessed mucosal surface.
As procedural video is analysed, detected findings populate a real-time detection panel visible to the endoscopist during the procedure. Each finding includes classification (polyp type, mucosal abnormality, anatomical landmark), morphological characterisation, estimated size, anatomical segment location, frame reference, and confidence score. The detection panel serves as a second observer — augmenting the endoscopist's visual assessment without interrupting procedural flow.
Every detection includes a confidence score (0.0–1.0). High-confidence findings (above 0.85) flagged with critical markers. Lower-confidence findings presented for clinician verification. Threshold configurable per institution.
Each detection linked to the exact video frame where it was identified. Clinicians click any finding to jump directly to the relevant frame for visual review and confirmation.
AXIVIS automatically segments the procedural video into anatomical phases — insertion, navigation, examination, intervention, and withdrawal. Each phase is timed, measured, and annotated. For colonoscopy, withdrawal time is calculated automatically against minimum quality standards (6-minute threshold). Adenoma detection rate is tracked per clinician over time. The system transforms procedural video from a passive recording into a structured, searchable, auditable clinical dataset.
AI identifies procedural phases based on visual landmarks, instrument positioning, and anatomical transitions. Phase boundaries marked automatically with timestamp references.
Key procedural quality indicators calculated automatically from video analysis. Institutional benchmarking against published quality standards. Per-clinician longitudinal quality tracking.
AXIVIS generates structured procedural reports that include procedure summary (indication, sedation, preparation quality), all findings with frame references and AI classification, interventions performed, complications assessment, and follow-up recommendations. The report integrates AI detections, clinician confirmations, and procedural quality metrics into a single structured document. The performing clinician reviews, edits, and approves before the report enters the patient record.
Quality metrics extracted automatically from video analysis and integrated into the procedural report. Institutional quality dashboards track metrics per clinician over time.
Complications documented with severity grading, timing, management actions, and outcome. Structured complication reporting enables institutional safety monitoring and regulatory compliance.
During interventional procedures, AXIVIS continuously monitors the visual field for signs of active bleeding — arterial spurting, oozing, submucosal haematoma formation. When bleeding is detected, the system logs the onset frame, anatomical location, estimated severity, and tracks the visual field continuously until haemostasis is confirmed. Post-intervention bleeding surveillance continues through the withdrawal phase. The bleeding detection module provides an additional safety layer for procedures involving polypectomy, biopsy, or mucosal resection.
Detected bleeding classified by visual characteristics. Arterial spurting flagged as critical with immediate alert. Oozing monitored with sustained tracking until resolution.
After intervention, the system monitors the polypectomy or biopsy site through subsequent frames. Haemostasis confirmed or flagged if bleeding recurs. Time-to-haemostasis logged in the procedural report.
All AI detections are decision support. The performing endoscopist or surgeon retains full clinical authority over procedural decisions. No autonomous intervention.
Each AI detection requires clinician acknowledgement — confirmed, modified, or dismissed. Only confirmed findings enter the structured procedural report.
Every frame-level inference logged with model version, input frame reference, detection output, confidence score, and the clinician who reviewed the finding.
Original procedural video preserved without modification. AI annotations are overlaid, never embedded. Full procedural recording available for retrospective review.
Gastroenterologists performing diagnostic and therapeutic endoscopy using AI-augmented detection to maximise adenoma detection rate and procedural quality compliance.
Surgical teams using laparoscopic and minimally invasive approaches with AI-assisted anatomical landmark recognition and procedural phase documentation.
Department leadership with visibility into procedural volumes, quality metrics, complication rates, and per-clinician performance benchmarking across the unit.
State-based diagnostic order lifecycle management across every department. Unique order identifiers, real-time status tracking, clinician notifications, and immutable audit trail. Orders transition through defined states — Pending, In Progress, Completed, Cancelled — with enforced governance at every stage. Completed orders become read-only. No diagnostic leakage.
Every diagnostic order follows a defined state machine. Transitions are enforced, logged, and irreversible. No order can skip a state or revert without explicit audit documentation.
Diagnostic orders span departments — a physician orders blood tests processed by the laboratory, imaging studies interpreted by radiology, histology specimens analysed by pathology, and genetic testing performed by the genomics unit. AXIVIS provides a unified order management layer where every order is visible regardless of which department processes it. The ordering clinician sees real-time status updates. The processing department receives structured order details. Results flow back to the patient record automatically upon completion.
Every order receives a system-generated unique identifier. No duplicate orders. No ambiguous references. Each identifier links to the ordering clinician, patient, test type, clinical indication, priority, and complete audit trail.
Orders classified by clinical urgency. STAT orders trigger immediate department notification. Priority-based queue sorting ensures the most clinically critical orders are processed first.
Ordering clinicians receive notifications at each state transition — order acknowledged, sample collected, processing started, results available. Critical results trigger immediate push notification to mobile.
Diagnostic leakage — the failure to follow up on ordered diagnostic tests — is among the most common and preventable causes of delayed diagnosis. Studies estimate that 7–8% of abnormal results are never communicated to patients. AXIVIS tracks every order from creation through result delivery to clinician review. Orders that produce results but remain unreviewed trigger escalating notifications. Orders that fail to produce results within expected timeframes are flagged for investigation. The system ensures that no diagnostic result falls into the gap between departments.
Each order tracked not just to result delivery, but to clinician review and documented action. A result that arrives but is never reviewed is functionally equivalent to a result that never arrived.
Unreviewed results trigger automated escalation. Initial reminder at 24 hours. Follow-up at 48 hours. At 72 hours, the order is escalated to the department head with audit documentation.
Leadership dashboard showing institutional diagnostic leakage rate, per-department review compliance, mean turnaround time by order type, and flagged orders requiring follow-up.
Every diagnostic order maintains a complete, immutable audit trail from creation through completion. Each state transition records the timestamp, the clinician or system that initiated the transition, the reason for the transition, and the order state before and after. Completed orders become read-only — no modification, no deletion, no retroactive changes. The audit trail is available for clinical governance review, regulatory inspection, and medico-legal documentation at any time.
Every transition between order states captured with full metadata. System-initiated transitions (e.g., auto-escalation) documented with the triggering rule and governance policy reference.
Once an order reaches Completed state and results are attached, the order record becomes immutable. No fields can be modified. Amendments require a new linked order with explicit cross-reference to the original.
Orders follow a defined state machine. No state can be skipped, reverted, or bypassed. Each transition requires authenticated clinician action or documented system trigger.
Every order tracked from creation through result review. Unreviewed results trigger escalating alerts. Orders without results beyond expected timeframes flagged automatically.
Completed orders become read-only. No modification, no deletion. Amendments require a new linked order with explicit audit cross-reference to the original.
Every order visible to the ordering clinician regardless of which department processes it. No orders lost in inter-departmental handoffs.
Physicians and specialists creating diagnostic orders with real-time visibility into order status, result delivery, and processing timeline across every department.
Laboratory, radiology, pathology, and genomics departments receiving structured order details with priority classification and clinical indication for efficient processing.
Medical directors and clinical governance teams monitoring diagnostic leakage rates, review compliance, turnaround times, and order lifecycle performance across the institution.
Upload lab reports in any format — PDF, image, HL7. AI extracts every biomarker, classifies abnormal values against reference ranges, generates contextual clinical interpretation, and tracks longitudinal trends across sequential reports. Integrated clinical screening tools for mental health, cervical cytology, and dermatological assessment.
Laboratory AI is deployed in active laboratory operations today. The six screens below trace a single critical haematology panel for Sarah Mitchell — 57-year-old patient, STAT HAEM order, Hb 6.8 g/dL, critical thrombocytopaenia, pancytopaenia — through every surface the clinical scientist and treating clinician interact with: departmental worklist, per-finding drill-down, structured prior comparison, full report interpretation, pending request orchestration, and departmental analytics.
The Laboratory AI worklist opens to the full departmental results queue. Six KPIs anchor the view: Results Today, Critical/STAT, Awaiting Review, AI Accuracy, Avg TAT with comparison against manual baseline, and Panels Active.
Every result row carries the full institutional ledger: accession number, priority chip (STAT · URGENT · ROUTINE), patient identity, panel taxonomy chip (HAEM · BIOCHEM · TUMOUR · MICRO), scientist attribution, and the AI-generated preliminary finding with confidence score. The first row — Sarah Mitchell · HAEM · 96% · CRITICAL: Hb 6.8 g/dL severe anaemia, WBC 0.9 critical leucopaenia, Plt 18 critical thrombocytopaenia — surfaces at the top by triage sort, not time.
Opening a report with prior results available surfaces the Prior Results tab automatically. An interval-change ribbon declares the departmental posture up front: 6 WORSENING · 2 STABLE. Three view modes — Cards, Chart, Table — for the same underlying data.
Each analyte renders as a structured card: gauge-indicator of current value against reference range, critical status chip, reference range, current → prior arrow with absolute and percentage change. Haemoglobin: 6.8 g/dL · Critical Low · Ref: 12–16 · 8.2 → 6.8 · ▼ 1.4 (-17.1%). Four structured fields — Current · Prior · Reference · Trend — followed by a Position Within Reference Range bar rendering the analyte's position as a marker on the normal band. Critical values carry an inline banner: "Critical value — immediate clinical review required. Notify treating clinician."
Opening any abnormal result opens a dedicated finding page. Title, panel chip, severity status, and ICD-10 coding at the top — in this view: Haemoglobin — Severe Anaemia · HAEM · ICD-10: D64.9 — Anaemia, unspecified · CRITICAL. AI Detection Confidence renders as a proportional bar at 96%.
RESULT VALUES & PARAMETERS surfaces the complete diagnostic vocabulary: Haemoglobin 6.8 g/dL (ref 12–16), MCV 104 fL (ref 80–100), MCH 35.1 pg (ref 27–33), Reticulocytes 0.4% (ref 0.5–2.5), ESR 88 mm/hr (ref <20) — every analyte with its own reference range rendered inline.
DESCRIPTORS renders the haematological pattern in report-ready prose: "Hb 6.8 g/dL — severely below reference range (12–16 g/dL). Macrocytic pattern (MCV 104 fL). Reticulocytopenia (0.4%) indicating impaired bone marrow response rather than haemolytic or haemorrhagic aetiology." CLINICAL SIGNIFICANCE translates pattern into action: "This result requires urgent clinical attention. Immediate correlation with clinical presentation and relevant specialist review is recommended."
The Interpretation tab opens with TEST PANELS — an ordered list of every analyte against its severity chip: Haemoglobin · Critical Low. White Blood Cells · Critical Low. Platelets · Critical Low. Neutrophils · Critical Low. Lymphocytes · Low. MCV · High. ESR · High. Reticulocytes · Low.
LABORATORY INTERPRETATION renders the full clinical synthesis in the prose conventions used by reporting haematologists: "Severe pancytopaenia with macrocytosis. Bone marrow failure pattern in context of known myeloid malignancy. Neutrophils critically low — infection risk extreme."
RECOMMENDATION surfaces explicit clinical actions: "Urgent haematology review. Consider G-CSF. Blood cultures if febrile. Transfusion threshold reached for both RBC (Hb <7) and platelets (<20)." PRIOR RESULTS AVAILABLE FOR COMPARISON renders every analyte as Prior → Now with a directional arrow. Eight analytes. Six trending down (▼▼). Two trending up (▲▲ for MCV and ESR — both clinically consistent with the interpretation).
The Pending Requests surface handles the full laboratory order lifecycle. Two filter rows at the top: status (ALL · STAT · URGENT · ROUTINE · PENDING · IN_PROGRESS · COMPLETED · REJECTED) and panel (HAEM · BIOCHEM · MICRO · COAG · IMMUNO · TUMOUR · SCREEN).
Every request row carries panel chip, patient identity, priority chip, order ID, test panel composition, originating department, ordering clinician, and specimen type. Selecting a row opens a structured detail panel on the right: Order ID LO-2026-04290, Clinician Dr. E. Mbeki, Department Oncology, Specimen EDTA, Placed 2026-03-30 06:00, Due 2026-03-30 09:00, Indication: "Pre-cycle bloods. Osimertinib cycle 8. Neutropenia monitoring." Five row actions — Take Order · Schedule · Assign · Upload · Reject.
Six KPIs anchor the Laboratory Analytics surface: Results Today 186, STAT Pending 6, Avg TAT 34m, Critical 8, Reported 142, Awaiting 44. A stacked HOURLY RESULT THROUGHPUT chart runs from 06:00 through 17:00.
RESULTS BY PANEL renders the departmental distribution as horizontal bars with percentages: HAEM 42 (23%) · BIOCHEM 58 (31%) · TUMOUR 24 (13%) · MICRO 19 (10%) · COAG 14 (8%) · IMMUNO 11 (6%) · SCREEN 18 (10%). SCIENTIST WORKLOAD lists every clinical scientist — Dr. Okafor 48 tests / 3 critical / 28m TAT / ONLINE · Dr. Adeyemi 39 tests / 1 critical / 32m · Dr. Mbeki 31 tests / 0 critical / 41m / OFFLINE · Dr. Osei 24 tests / 2 critical / 38m.
AI INTERPRETATION PERFORMANCE surfaces the six governance metrics that matter:
Lab reports arrive in every format. AXIVIS normalises them all into structured, queryable clinical data.
Uploaded laboratory reports are processed through multi-stage extraction. AI identifies individual biomarkers, parses numeric values and units, maps each result against age- and sex-adjusted reference ranges, and classifies findings as Normal, Abnormal, or Critical. The system generates contextual interpretation for each result — not just whether a value is high or low, but what the clinical significance may be in the context of the patient's history, medication list, and concurrent findings.
Biomarker names, values, units, and reference ranges extracted from unstructured documents using combined OCR and natural language processing. Units normalised to standardised formats for cross-laboratory comparability.
Each result classified against demographically appropriate reference ranges. Paediatric, geriatric, and pregnancy-specific ranges applied automatically based on patient profile.
Beyond flag-and-reference classification, AI generates brief contextual interpretation for abnormal findings — potential clinical significance, common differential considerations, and suggested follow-up investigations.
Individual lab results provide limited clinical value in isolation. The same value that is normal for one patient may represent a significant deterioration for another when viewed against their baseline. AXIVIS automatically matches current results against all prior laboratory data for the same patient, calculates the trajectory, and alerts clinicians to clinically significant trends — rising creatinine suggesting progressive renal impairment, falling haemoglobin indicating ongoing blood loss, or climbing HbA1c reflecting deteriorating glycaemic control.
Each biomarker tracked longitudinally with automated trend calculation. Sustained directional changes flagged with rate of change and projected trajectory. Alert thresholds configurable per biomarker and per institution.
Simultaneous trends across related biomarkers identified automatically — rising creatinine with falling eGFR confirms renal trajectory; falling haemoglobin with rising ferritin suggests inflammatory anaemia rather than iron deficiency.
Standardised clinical screening tools integrated natively within the platform. Scores calculated automatically, severity classified, and results tracked over time.
AI-extracted values displayed alongside the source document for visual verification. Clinicians confirm extracted values match the original report before data enters the patient record.
All contextual interpretations are decision support. Clinical significance assessment requires qualified clinician judgement in the context of the full patient presentation.
Results classified as critical trigger immediate notification to the ordering clinician. Critical alert acknowledged receipt logged with timestamp and clinician identity.
Original laboratory documents (PDF, image, HL7) retained alongside extracted structured data. Full provenance from source document to structured record maintained.
Primary care and specialist physicians reviewing laboratory results with AI-augmented interpretation, trend analysis, and cross-biomarker correlation at the point of clinical review.
Laboratory leadership with visibility into result turnaround, critical value notification compliance, and extraction accuracy metrics across the laboratory operation.
Mental health, cervical screening, and preventive health teams using integrated validated screening instruments with automated scoring and longitudinal outcome tracking.
Direct VCF ingestion with automated variant annotation, ACMG classification, pharmacogenomic cross-referencing, and clinical actionability scoring. Germline and somatic analysis unified within a single clinical intelligence environment. Every genomic output advisory — clinician interpretation mandatory.
Every major clinical sequencing format processed natively through the same variant interpretation pipeline.
Uploaded VCF files are processed through a multi-stage annotation pipeline. Each variant is cross-referenced against ClinVar, gnomAD, COSMIC, and institutional databases, then classified using ACMG/AMP criteria into five tiers: Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, and Benign. Classification evidence is documented — population frequency, functional predictions, segregation data, and literature references. The clinical geneticist reviews every classification before it enters the patient record.
Standardised classification using the American College of Medical Genetics criteria. Each tier determined by aggregation of evidence codes (PVS1, PS1-4, PM1-6, PP1-5, BA1, BS1-4, BP1-7).
Each variant queried against population frequency databases, clinical significance repositories, somatic mutation catalogues, and pharmacogenomic knowledge bases simultaneously.
Beyond classification, each pathogenic or likely pathogenic variant assessed for clinical actionability — does this finding change screening, treatment, or management for this patient?
Clinical genomics requires distinguishing between inherited germline variants (present in every cell, passed to offspring, informing hereditary risk) and acquired somatic mutations (tumour-specific, informing treatment selection). AXIVIS processes both analysis types through the same pipeline, with clear labelling and distinct clinical pathways. Germline findings trigger hereditary risk assessment and family screening recommendations. Somatic findings feed into AXV-11 Oncology Intelligence for treatment pathway integration.
Hereditary cancer syndromes (BRCA1/2, Lynch, Li-Fraumeni), cardiac conditions (LQTS, HCM), pharmacogenomic profiles. Findings trigger cascade testing recommendations for at-risk family members.
Tumour-specific variant allele frequencies, driver mutations, actionable therapeutic targets, resistance mutations. Integrated with oncology pathway for treatment decision support.
Genomic findings from AXV-12 feed directly into AXV-11 Oncology Intelligence. Variant classifications, therapeutic targets, and trial eligibility criteria are available within the oncology treatment pathway without data re-entry.
Pharmacogenomic profiling identifies how a patient metabolises specific drugs based on their genetic profile. AXIVIS cross-references genotyped pharmacogenes (CYP2D6, CYP2C19, CYP3A4, DPYD, TPMT, UGT1A1) against the prescribed medication list to generate dosing guidance. Poor metabolisers, intermediate metabolisers, and ultra-rapid metabolisers identified with clinical recommendations. This intelligence integrates with AXV-04 Consultation Suite prescription safety checking — genomic drug-gene interactions flagged at the point of prescribing.
Each pharmacogene genotyped and mapped to metaboliser phenotype. Dosing recommendations generated per CPIC and DPWG guidelines. Interactions flagged before prescribing occurs.
Pharmacogenomic findings automatically available to the Consultation Suite prescription safety engine. When a clinician prescribes a drug with a known pharmacogenomic interaction, the system flags the genotype-specific risk before the prescription is finalised.
All AI-generated variant classifications are decision support. Final interpretation remains the responsibility of the clinical geneticist or molecular pathologist. No autonomous clinical reporting.
Every classified variant reviewed by a qualified clinician before entering the patient record. VUS findings explicitly flagged for ongoing reclassification monitoring.
Every classification linked to its evidence base — database references, population frequencies, functional predictions, and literature citations. Full audit trail from raw VCF to final clinical report.
Genomic data processed and stored under the same AES-256 encryption, RBAC, and data residency controls as all AXIVIS clinical data. Country-level genomic data residency configurations available.
Specialists interpreting germline variants for hereditary risk assessment, carrier screening, and predictive testing with AI-augmented classification and evidence aggregation.
Pathologists analysing somatic tumour profiles for therapeutic target identification, resistance mutation detection, and molecular subtyping to guide oncology treatment.
Physicians using pharmacogenomic profiles to optimise drug selection and dosing — with genotype-specific alerts integrated into the prescribing workflow at the point of care.
CNN-based medical imaging analysis across seven modalities with structured report generation, key finding extraction, clinical impression synthesis, and radiologist worklist intelligence. Every output requires qualified clinician review before clinical use.
What follows is the shipping Radiology AI product — patient-grade interface, clinician-validated workflow, and every feature you see in the screenshots live in active institutional deployments today. The examples below walk through an 8mm solid pulmonary nodule in a 57-year-old patient across every tab a radiologist touches: interpretation, key findings, impression, structured report, serial comparison, DICOM viewing, pending orders, and departmental analytics.
The interpretation surface opens with a structured list of the anatomical regions covered by the study — Right Lower Lobe, Left Lung, Mediastinum, Lymph Nodes, Liver, Spleen, Kidneys, Adrenals, Pelvis — followed by a full imaging interpretation written in the prose and rhythm of a dictated report.
Prior study comparison is surfaced inline. PRIOR STUDY AVAILABLE · SCAN 1 OF SERIES · CT · 2023-11-14 · ACC-71204. Each prior finding compared against current: No pulmonary nodule → N/A → NORMAL, Centrilobular emphysema → Mild → REVIEW. The radiologist sees delta, not just current state.
Findings are not extracted as a flat list. Each is rendered as a structured card: clinical title, interval-change chip (WORSENING · STABLE · NORMAL), severity status (CRITICAL · REVIEW · NORMAL), organ tag, ICD-10 code, clinical description, AI confidence bar, and a dense PRIOR → CURRENT comparison row with actual measurements.
The first card on this study: Solid pulmonary nodule · WORSENING · CRITICAL · Right Lower Lobe · ICD-10 R91.1. 91% confidence. Prior: Not identified. Current: 8mm × 6mm. The card writes itself from CNN detection plus prior-study delta — the radiologist sees, confirms, signs.
Clicking any finding card opens a dedicated page for that finding alone. Title, organ tag, severity chip at the top. AI Detection Confidence rendered as a proportional bar — 99% for unremarkable solid organs in this view.
Measurements surface structured, organ-by-organ: Liver 14.5cm craniocaudal — upper limit of normal · Spleen 9.8cm — normal · Kidneys Right 10.2cm, Left 10.6cm — normal · Adrenals Bilateral limbs ≤5mm — normal. Descriptors render below in report-ready prose. A clinical significance block renders the clinical posture in one line. "Ask AI about this finding" opens a Cortex context bound to this specific finding.
The Impression tab renders the full structured report in the format used across radiology departments worldwide. STUDY INFORMATION — modality, body parts examined, study description, date. TECHNIQUE — reconstruction detail: "Multidetector CT chest, abdomen and pelvis acquired in portal venous phase following 80ml IV iohexol 350 at 3ml/s. Reconstructions at 1.25mm axial, coronal and sagittal."
The IMPRESSION block cites guidelines by name: "Per Fleischner Society 2017 guidelines for solid nodules ≥6mm in a high-risk patient, follow-up LDCT at 3 months is recommended to assess for interval growth." The FINDINGS block reads as structured report text — Lungs and airways, Mediastinum, Abdomen and pelvis — in the exact conventions the attending radiologist dictates in.
Reporting templates are not free text with headings. Each is a structured schema bound to the governing international guideline: Free Text, Fleischner (Nodule), Lugano (Lymphoma), ASPECTS (Stroke), BI-RADS (Breast), TI-RADS (Thyroid).
Clinical history surfaced from the referral: "Known smoker, 35 pack-years. Presenting with haemoptysis ×3 days. Prior CT chest 2023 unremarkable." Findings, Impression, and Recommendations each carry their own Auto-fill AI and Dictate actions. The Recommendations block carries an Auto-Guidelines toggle that pulls from the Fleischner Society 2017 and GOLD Guidelines 2024 directly.
The Comparison tab renders the prior and current studies in parallel viewports with synchronised navigation. PRIOR STUDY · CT · 2023-11-14 · ACC-71204 on the left. CURRENT STUDY · CT · 2026-03-30 · ACC-83921 on the right. Window and level values (W:350 · L:50) surfaced in the viewport chrome.
The new 8mm nodule is annotated directly on the current study — "8mm NEW" label pointing to a dashed-red ROI in the right lower lobe. Below, INTERVAL CHANGE · FINDING BY FINDING renders every finding with a prior/current delta. In this study: "Solid pulmonary nodule · Right Lower Lobe · WORSENING · CT Chest Nov 2023: Not identified → Current: 8mm × 6mm · NEW — interval development over 28 months". An AI PREDICTIVE ANALYSIS block follows.
From any report tab, DICOM Viewer opens the full AXIVIS Imaging Suite on the underlying study — dual-canvas rendering, full measurement palette, window/level presets, multi-planar reconstruction.
In this view, the CT chest is rendered with the AI overlay engaged (AI ON). Two AI detection markers visible directly on the image: AI 91% · Right Lower Lobe and AI 88% · Bilateral Lungs — rendered as semi-transparent coloured ROIs anchored to the CNN detection coordinates. The radiologist can toggle the AI overlay off at any time, adjust confidence threshold, and interrogate any region with the ROI AI tool.
Five departmental KPIs render at the top of the analytics surface: Studies Today, Avg Turnaround with per-target comparison, AI Accuracy with radiologist override rate, AI Flags with critical subset, and Critical Alerts unacknowledged count.
Hourly Throughput stacked by modality — CT, MRI, XR, PET segments from 06:00 onward. Turnaround Time by Modality rendered as horizontal bars with per-modality target: CT 4.1m · MRI 6.8m · XR 2.4m · PET 9.2m · Department Average 5.6m.
Six order-state counters render at the top: Total Orders 8 · Pending 4 · In Progress 1 · Scheduled 1 · Completed Today 0 · Rejected 1. Search by patient, order number, or department. Filter by modality, priority, or status.
Each row carries the full institutional order record: Order No (RO-2026-00812), placed timestamp, priority chip (URGENT · ROUTINE · STAT), patient identity, modality chip (MAMMO · PET · NM · MRI · US · CT), protocol, clinical indication, assigned radiologist, target date, and per-row actions. Overdue orders carry an OVERDUE flag rendered in red below the status chip.
Each modality processed by dedicated CNN models trained on annotated clinical imaging datasets.
AXIVIS Radiology AI processes uploaded imaging studies through modality-specific convolutional neural network models. The system identifies anatomical structures, detects potential abnormalities, characterises findings by location and morphology, and generates structured interpretations with confidence scoring. Every AI finding is annotated directly on the imaging study for immediate radiologist review.
Each detected finding is overlaid on the imaging study with a confidence percentage. Radiologists see AI markers (AI 88%, AI 91%) directly on the scan, enabling rapid visual correlation between AI detection and anatomical context.
One-click window presets optimised for each tissue type. Custom window width and level adjustment with real-time slider controls.
Four-tab report generation accessible directly from the viewer toolbar. AI-generated structured reports with clinician sign-off before finalisation.
AXIVIS generates structured radiology reports across four output tabs: Interpretation (systematic anatomical review with findings), Key Findings (extracted list with location, measurements, and classification), Impression (clinical summary with recommendations), and Metadata (study parameters, comparison studies, technical quality). The reporting clinician reviews, edits, and approves the generated report before it enters the patient record. No report is finalised without clinician sign-off.
Systematic separation of descriptive findings, extracted data points, clinical synthesis, and technical parameters.
Every section of the generated report is editable. The radiologist or reporting physician has full authority to modify, correct, or override any AI-generated content.
AXIVIS includes a fully integrated DICOM viewer within the web platform. Clinicians open and review imaging studies directly in the browser with professional-grade visualisation tools. ROI AI analysis enables region-specific AI interpretation with confidence-scored annotations. The toolbar provides ruler measurement, angle calculation, pan, zoom, window/level adjustment, and invert capabilities — all within a single unified interface.
Select any region on the imaging study for targeted AI analysis. The system returns confidence-scored findings with anatomical localisation and clinical significance assessment.
Complete diagnostic imaging toolkit accessible from a single toolbar row. Snapshot capture and study loading for multi-series navigation.
Full clinical workflow from worklist triage through peer review, multidisciplinary team submission, and final approval with digital signature.
Radiology departments process hundreds of imaging studies daily. AXIVIS assigns priority scores based on initial AI assessment of clinical urgency — STAT cases flagged immediately, urgent cases elevated, routine cases queued appropriately. The radiologist's worklist is optimised so the most clinically critical studies are reviewed first. Priority scoring is advisory — the radiologist retains full authority to re-prioritise at any time.
Every study receives a numerical priority score based on clinical context, referral urgency, AI preliminary assessment, and patient acuity indicators.
Studies with findings suggestive of acute pathology (stroke, PE, pneumothorax, fracture) flagged for immediate radiologist attention. Real-time push notifications to mobile app.
Department heads see real-time study volumes, completion rates, turnaround times, and pending worklist depth across all radiologists.
Incidental findings and known lesions require monitoring across sequential imaging studies. AXIVIS automatically compares measurements from current and prior studies, calculates volumetric change, and applies monitoring criteria (Fleischner, Lung-RADS, BI-RADS) to generate structured follow-up recommendations. The system tracks the trajectory — growth rate, doubling time, stability — not just the latest measurement.
Current findings automatically matched against prior imaging studies for the same patient. Measurement delta calculated with percentage change and absolute difference.
Evidence-based monitoring guidelines applied automatically. Follow-up interval recommendations generated based on finding characteristics and change trajectory.
Quantitative growth analysis for serial lesion measurements. Exponential growth patterns flagged for accelerated clinical review.
All AI-generated findings and reports are decision support. Final radiology interpretation remains the responsibility of qualified radiologists and physicians. No autonomous diagnosis.
Every section of the generated report is fully editable. The reporting clinician reviews, corrects, and approves before any report is finalised or enters the patient record.
Every AI inference logged with the specific model version, input study reference, output generated, confidence scores, and the reviewing clinician who signed off.
Original DICOM imaging data preserved without modification throughout the analysis, viewing, and reporting workflow. Annotations are overlaid, never embedded.
Primary reporting clinicians using AI-assisted analysis for structured interpretation, finding extraction, and report generation across all supported imaging modalities.
Clinicians ordering imaging studies who access structured reports, key findings, and clinical impressions within the patient record and through AXIVIS Cortex.
Department leadership with visibility into study volumes, turnaround times, triage effectiveness, and workflow compliance across the entire imaging operation.
Zero-footprint, browser-delivered DICOM workstation with embedded clinical reasoning. Dual-canvas rendering, twelve measurement primitives, multi-planar reconstruction, and AXIVIS Vision per-frame analysis — integrated with PACS through standard DICOMweb.
The Imaging Suite is not a single component. It is five tightly-integrated primitives, each engineered for its clinical purpose and deployed as a single workflow.
The screenshots below are from a live institutional deployment. Patient identifiers redacted; interface unchanged.
Every frame flows through a six-stage pipeline. Redundant draws are elided. State changes are the only trigger for a render pass.
Default window/level, modality-specific layout intelligence, and colour-coded UI for instant visual identification on multi-study worklists.
Hero statistics at the top: Studies, Critical, Notable, Frames Analyzed, Normal. Modality filters, severity sort, and bulk operations. 20 studies per page with status chips — URGENT, STAT, AI REVIEWED, PENDING REVIEW.
Connects to any standards-conformant DICOMweb endpoint. No middleware. No proprietary driver. Full bidirectional DICOM GSPS for presentation state round-trip.
All endpoints mounted under the gateway prefix. JWT-authenticated. Full OpenAPI specification available on request.
The Imaging Suite is designed explicitly as an augmentation layer — not an autonomous diagnostic device. Every imaging AI output is framed as a preliminary reading requiring clinical correlation.
The Imaging Suite is deployed in clinical environments today. Schedule a procurement-grade walkthrough with the AXIVIS team — DICOM workflow, PACS integration, security posture, and institutional licensing covered end-to-end.
Centralised patient records with AI-generated health insights, diagnostic ordering suggestions, and medication safety checking. Twelve integrated tabs spanning clinical overview, diagnostic reports, imaging, genomics, oncology, prescriptions, and the full patient timeline. Every module's output converges in the patient record.
The patient record is the convergence point for every AXIVIS module. Imaging, genomics, laboratory, oncology, prescriptions — all accessible from a single tabbed interface.
Traditional patient records are passive repositories — they store data without analysing it. AXIVIS applies AI across the complete patient dataset to generate health insights: risk patterns identified from longitudinal data, medication interactions flagged from the current prescription list, diagnostic suggestions based on presenting symptoms cross-referenced with medical history, and screening reminders triggered by age, sex, and risk profile. Every insight is advisory and requires clinician review before action.
AI analyses across data types simultaneously — rising HbA1c from labs, declining eGFR from renal function, BRCA1 status from genomics, and family history from the medical record. Patterns that span data silos are surfaced automatically.
Risk signals identified from data trajectories before clinical symptoms manifest. Deteriorating renal function flagged for nephrology review. Rising inflammatory markers correlated with imaging findings. Pharmacogenomic interactions detected before prescribing.
Automated screening recommendations based on national guidelines, adjusted for individual risk profile. BRCA1 carriers receive enhanced breast screening reminders. Diabetic patients receive retinal and renal screening prompts.
The patient record is not a standalone module — it is the convergence point for every other module in the platform. Consultation notes from AXV-04 appear in the Notes tab. Diagnostic orders from AXV-07 appear in the Orders tab. Lab results from AXV-08 appear in the Reports tab. Radiology findings from AXV-09 appear in the Reports tab. Oncology pathway data from AXV-11 appears in the Oncology tab. Genomic results from AXV-12 appear in the Genetics tab. The AI reasons across all of this data simultaneously to generate the health insights that appear in the Overview tab.
Overview (AI insights + summary), Reports (lab + imaging + pathology), Appointments (past + upcoming), Orders (diagnostic lifecycle), Medical History (conditions + surgeries + family), Billing, Notes (consultation + clinical), Oncology, Genetics, AI Assistant (conversational), Prescriptions, and Logs (audit trail).
The AI Assistant tab provides a conversational interface with AXIVIS Cortex, pre-loaded with the complete patient context. Clinicians ask questions about the patient — "What is the renal function trend?", "Are there any drug-gene interactions?" — and receive responses informed by the full patient dataset.
The Prescriptions tab integrates with AXV-04 Consultation Suite and AXV-12 Genomic Intelligence to provide comprehensive medication safety. Drug-drug interactions checked across the complete medication list. Drug-allergy cross-referencing against documented allergies. Drug-gene interactions flagged from pharmacogenomic profiling. Age, weight, and pregnancy-adjusted dosing verification. Duplicate therapy detection. Renal and hepatic dose adjustments recommended based on current lab results. Every safety check documented and auditable.
Five simultaneous safety checks on every prescription: drug-drug interactions, allergy cross-reference, pharmacogenomic interactions, dose appropriateness (age/weight/organ function), and duplicate therapy detection.
Current eGFR and liver function tests automatically inform dosing recommendations. Medications requiring renal dose adjustment are flagged when eGFR drops below specified thresholds. Metformin flagged at eGFR <30, gentamicin dose calculated from current creatinine clearance.
All AI-generated health insights are decision support. Clinical action requires qualified clinician review. No automated clinical decisions are made from AI insights.
AI insights explicitly flag when data is incomplete or when a finding is based on limited information. Confidence indicators reflect data quality and completeness.
Prescription safety checks are enforced at the point of prescribing. Critical interactions cannot be overridden without documented clinical justification.
Patient record access governed by RBAC with document-level permissions. Every access logged with clinician identity, timestamp, and pages viewed.
Physicians, specialists, and allied health professionals accessing the unified patient record with AI-augmented insights, cross-module data, and medication safety intelligence at the point of care.
Patients accessing their own health record through the patient portal — viewing AI health summaries, upcoming appointments, medication lists, and shared clinical documents.
Multidisciplinary team members coordinating complex care pathways with full visibility into the patient's cross-departmental clinical activity, diagnostic results, and treatment plans.
Appointment management with integrated AI Scribe. NLP converts consultation dialogue into structured clinical notes in real time — SOAP format, discharge summaries, referral letters. The clinician reviews and approves before any note is finalised. Every consultation documented in under 60 seconds. Every word clinician-validated.
AXIVIS scheduling integrates appointment management directly with the clinical workflow. Appointments link to patient records, clinical history, and prior consultation notes before the patient arrives. Clinicians see their daily schedule with patient context pre-loaded. Reception staff manage bookings through a dedicated dashboard. Urgent and walk-in appointments slot into the schedule with priority flags. Every appointment becomes the entry point for the AI Scribe — when the consultation begins, documentation starts automatically.
Before the appointment starts, the clinician sees the patient's relevant history, prior consultation notes, outstanding test results, and active medication list. No chart review required — context is pre-loaded.
Department-specific scheduling views with configurable slot durations, appointment types, and capacity limits. Cross-department booking for referrals and multi-disciplinary appointments.
Automated patient communications at booking confirmation, 48-hour reminder, day-of-appointment arrival instructions, and post-consultation follow-up with any actions or prescriptions.
When a consultation begins, the AI Scribe activates and transcribes the dialogue in real time using medical-grade automatic speech recognition with speaker differentiation. The system distinguishes between clinician and patient speech, captures medical terminology with clinical accuracy, and maintains the conversational flow as structured text. The clinician conducts the consultation normally — no dictation, no templates, no keyboard. The AI Scribe handles the documentation layer entirely.
AI distinguishes between clinician and patient voices using speaker diarisation. Multi-speaker consultations (family members, interpreters, multidisciplinary meetings) handled with per-speaker attribution.
Speech recognition trained on clinical vocabulary — drug names, dosages, anatomical terms, procedure names, diagnostic terminology. Medical accuracy, not generic transcription.
Transcription appears in real time as the consultation progresses. The clinician can glance at the transcript during the consultation to verify key points are captured correctly.
After the consultation ends, the AI Scribe transforms the raw transcript into a structured clinical note — SOAP format (Subjective, Objective, Assessment, Plan), discharge summaries, or referral letters depending on the consultation type. The system extracts clinical entities: symptoms, examination findings, diagnoses, medications prescribed, investigations ordered, follow-up plans, and safety-netting advice. The structured note appears within seconds of the consultation ending. The clinician reviews, edits if needed, and approves with a single click.
The standard clinical note format used across primary and secondary care. Each section populated automatically from the consultation transcript with appropriate clinical language.
The same consultation transcript can generate multiple output formats — a SOAP note for the clinical record, a referral letter for the specialist, and a patient summary letter. Each format uses appropriate clinical language and structure.
From the moment the consultation ends to a clinician-approved, signed clinical note in the patient record — under 60 seconds. The documentation burden that consumes 49% of physician time, eliminated.
No AI-generated note enters the patient record without explicit clinician review and approval. The clinician reads, edits if needed, and signs off before finalisation.
Every section of the generated note is fully editable. The clinician retains complete authority to modify, correct, add, or remove any content before approval.
The original consultation transcript is retained alongside the structured note. Any discrepancy between transcript and note can be reviewed and resolved.
Consultation audio is processed for transcription only. Audio data is not stored after transcription unless explicitly configured by the institution. Patient consent workflow integrated.
Clinicians conducting consultations with AI-automated documentation — eliminating the administrative burden of note-writing while maintaining full clinical control over the final record.
Administrative staff managing appointment bookings, patient scheduling, and clinic capacity through a dedicated reception dashboard with calendar views and notification management.
Practice and clinic managers monitoring appointment utilisation, no-show rates, average consultation duration, and documentation completion times across the practice.
End-to-end encrypted video consultations between clinician and patient, fully integrated with the AXIVIS scheduling system, patient records, and AI Scribe documentation. The clinician conducts the remote consultation with the same clinical tools available in face-to-face encounters — access to patient history, concurrent laboratory results, imaging studies, and real-time AI transcription. No separate telehealth platform required.
AXIVIS Telehealth is not a standalone video platform bolted onto the clinical workflow — it is embedded within it. When a scheduled telehealth appointment begins, the video consultation opens within the AXIVIS environment alongside the patient's clinical record, medication list, outstanding results, and prior consultation notes. The clinician sees the patient and their data simultaneously. The AI Scribe from AXV-04 activates automatically, transcribing the remote consultation in real time with the same speaker differentiation and SOAP note generation as in-person encounters.
The telehealth interface displays the video feed alongside the patient's clinical context — no switching between windows, no separate logins, no context loss between video platform and clinical system.
When the telehealth consultation begins, AXV-04 AI Scribe activates automatically. The remote conversation is transcribed in real time, structured into SOAP format, and presented for clinician review at consultation end — identical to in-person workflow.
Clinicians can share specific clinical data with the patient during the consultation — imaging studies, laboratory trends, genomic reports — enabling informed shared decision-making in real time.
AXIVIS Telehealth does not exist as a separate tool — it is a delivery mode for the full clinical platform. During a telehealth consultation, every module available in face-to-face encounters remains accessible. The clinician can order investigations through AXV-07, review imaging through AXV-09, check laboratory trends through AXV-08, and prescribe medications through AXV-04 — all without leaving the consultation. The patient experience mirrors in-person care: the clinician is attentive, not distracted by separate systems, because the clinical tools are embedded within the same interface as the video feed.
Patients join a virtual waiting room before the consultation begins. The system tests audio/video connectivity, displays the pre-visit questionnaire if configured, and notifies the clinician when the patient is ready.
Support for multi-party video consultations — family members joining from separate locations, interpreter services, and multidisciplinary team meetings with multiple clinicians and the patient simultaneously.
Patients access telehealth consultations through the AXIVIS Patient App (iOS/Android) or web browser. No software installation required for the patient. Link-based join with authentication.
Remote clinical consultations carry the same confidentiality requirements as in-person encounters — and additional risks from data transmission over public networks. AXIVIS Telehealth applies end-to-end encryption to all video, audio, and screen-sharing streams using TLS 1.3 with certificate pinning. No consultation data is stored on third-party servers. Session recordings, if enabled, are encrypted and stored within the AXIVIS Vault under the same access controls as all clinical documents. Every consultation session is logged with participant identities, connection timestamps, duration, and encryption verification.
All video, audio, and data streams encrypted end-to-end. No intermediary can access consultation content. Certificate pinning prevents man-in-the-middle attacks.
Both clinician and patient authenticate before joining. Patient consent for telehealth consultation recorded. Session metadata (not content) logged for governance: who joined, when, duration, connection quality.
Telehealth runs on AXIVIS infrastructure — no Zoom, no Teams, no third-party video platform. Clinical data never transits through external servers. The same compliance certifications (ISO 27001, SOC 2 Type II, HIPAA) cover telehealth as all other AXIVIS modules.
All video, audio, and screen-share streams encrypted with TLS 1.3 and certificate pinning. No intermediary access to consultation content at any point in transmission.
Telehealth consent recorded before each consultation begins. Consent status documented in the session log and the patient record. Configurable per institution.
Participant identities, join/leave timestamps, connection duration, encryption status, and AI Scribe activation all logged per session. Available for governance review.
No third-party video platforms. All telehealth traffic runs on AXIVIS infrastructure under the same ISO 27001, SOC 2 Type II, and HIPAA compliance certifications.
Clinicians conducting follow-up appointments, medication reviews, results discussions, and triage assessments with patients who cannot attend in person — with full clinical tooling available throughout.
Patients in geographically remote or underserved areas accessing specialist consultations, multidisciplinary team input, and ongoing care management without travel burden.
Multi-party clinical discussions combining physicians, specialists, patients, and family members in a single encrypted session with shared access to clinical data and imaging.
AXIVIS Cortex is the institutional intelligence layer that operates across every module. It answers clinical queries, interprets imaging, reviews drug interactions, summarises literature, and predicts diagnostic trajectories — all within the context of the data currently on screen. Standalone mode for general clinical intelligence. Floating mode for page-specific context. Patient mode for dedicated per-patient reasoning. Every output advisory. Every response clinician-validated.
Cortex adapts its context window based on where it is invoked — general clinical queries, page-specific intelligence, or deep patient-level reasoning.
Standalone Cortex is the full-page clinical AI interface. Clinicians ask any medical question and receive structured, evidence-referenced responses. The system accesses six capability domains simultaneously: Imaging Analysis (interpret DICOM findings and imaging differentials), Oncology Protocols (treatment lines, chemotherapy regimens, response criteria), Genomic Insights (variant classifications, mutation burden, targeted therapy), Lab Interpretation (biomarker panels, reference ranges, pathology analysis), Literature Synthesis (clinical evidence, trials, guidelines), and Drug Intelligence (interactions, dosing protocols, formulary review).
Each domain represents a specialised reasoning module. Cortex routes queries to the appropriate domain and synthesises cross-domain responses when a question spans multiple areas.
Cortex has read access to data from all connected departments. A query about a specific imaging finding can reference laboratory context, genomic data, and oncology treatment history simultaneously.
Each Cortex session maintains conversational context. Clinicians can start new sessions, export full transcripts for documentation, and review query history for reference.
The floating Cortex panel appears on every page within the AXIVIS platform. It is aware of the current context — which module is active, which patient record is open, which data is displayed on screen. When a clinician is reviewing a radiology report, Cortex suggests queries about the imaging findings. When viewing a genomic panel, it surfaces questions about variant significance. The suggestions are not generic — they are generated from the actual data currently visible. Department badges (RAD, ONC, GEN, LAB, TRIALS, ICU) indicate which cross-departmental intelligence streams are active.
Cortex automatically ingests the data currently displayed on the active page. When a clinician asks a question, the AI has already loaded the relevant context — no copy-pasting data, no switching windows, no manual context provision.
Suggested queries adapt to the current view. On a patient overview, Cortex suggests reviewing critical flags. On an oncology timeline, it suggests examining treatment deltas. On a genomic report, it flags variant alerts requiring attention.
Beyond text queries, clinicians can use voice input for hands-free clinical questions or attach clinical files (DICOM, PDF, VCF, images) directly to the Cortex panel for immediate AI analysis.
Every patient in AXIVIS has a dedicated Cortex instance. When a clinician opens a patient's record and activates Cortex, the AI loads the complete clinical dataset for that specific patient — every consultation note, every lab result, every imaging report, every genomic finding, every medication, every procedure. The clinician can then ask patient-specific questions: "What is this patient's creatinine trend over the last 6 months?", "Are there any drug interactions with the current medication list?", "Based on the genomic profile and tumour staging, which clinical trials is this patient eligible for?" Cortex reasons across the full longitudinal patient record, not just the data currently on screen.
The patient-dedicated Cortex loads the entire clinical history. Longitudinal trends, cross-modal correlations, and temporal patterns are all available for AI reasoning — spanning years of clinical data in a single query.
Based on the patient's complete history, Cortex can model diagnostic trajectories — predicting likely progression, suggesting investigations that would resolve diagnostic uncertainty, and flagging risk factors that require monitoring.
Ask Cortex to correlate a rising tumour marker with the latest imaging findings and genomic profile. The AI synthesises across data types that would normally require manual cross-referencing across multiple systems and departments.
All Cortex responses are clinical decision support. Cortex does not perform autonomous diagnosis, treatment selection, or prescribing. Every output requires clinician interpretation and validation.
Cortex refuses out-of-scope queries, flags insufficient data for reliable response, and declines unsafe or unsupported requests. The system will not generate responses beyond its validated capabilities.
Every Cortex query logged with: input text, model version, full response, context window contents, timestamp, and the clinician identity. Complete audit trail from question to answer.
All Cortex outputs display the regulatory disclaimer: "AI-generated responses · CE MDR 2017/745 · Not for direct clinical decision." Visible on every response and every interface mode.
Every physician, specialist, and allied health professional using AXIVIS has access to Cortex — from general medical queries to patient-specific diagnostic reasoning, across every department and every module.
MDT discussions supported by Cortex cross-modal reasoning — correlating imaging, genomics, laboratory, and treatment data in real time during tumour board and clinical decision meetings.
Trainees and junior clinicians using Cortex for evidence-based learning — literature synthesis, guideline retrieval, and clinical reasoning support with full citation backing.
Encrypted messaging between clinicians and between clinicians and patients. No AI processing on message content. Role-based access controls enforced at the thread level. Every message logged with sender identity, recipient identity, and timestamp. Clinical attachments supported — share lab results, imaging reports, and referral documents directly within the conversation thread.
Clinical conversations about patient care happen constantly — between GPs and specialists, between radiologists and oncologists, between surgeons and anaesthetists. Currently, these conversations happen through email, WhatsApp, pager systems, and corridor conversations — none of which create a clinical audit trail, none of which are encrypted to healthcare standards, and none of which are linked to the patient record. AXIVIS Physician Connect provides a secure messaging channel that exists within the clinical environment, linked to patient records, encrypted end-to-end, and fully auditable.
Messaging threads linked to specific patient records inherit the access controls of that patient's data. Only clinicians with authorised access to the patient can participate in patient-linked threads.
Share clinical documents directly within the messaging thread. Attached files inherit the same encryption and audit controls as all AXIVIS Vault documents. No need to download, re-upload, or use external file-sharing.
Physician Connect is explicitly excluded from AI processing. Message content is not analysed, summarised, or processed by any AI model. Communication between clinicians remains private and human-only.
Patients frequently need to communicate with their clinicians between appointments — asking about medication side effects, confirming appointment details, requesting result updates, or reporting symptom changes. Currently, this requires phone calls to reception, callback waiting, and verbal communication that leaves no record. Physician Connect provides a secure messaging channel between clinician and patient, delivered through the AXIVIS Patient App and Patient Portal. Messages are encrypted, linked to the patient record, and create a documented communication trail.
Patient messages delivered via push notification to the AXIVIS Patient App (iOS/Android) or accessible through the Patient Web Portal. Patients respond at their convenience — no hold times, no callback slots.
All clinician-patient messages become part of the patient record. Follow-up instructions, medication clarifications, and clinical advice are documented — not lost in phone conversations or informal channels.
Clinicians attach patient-facing documents — consultation summary letters, result explanations, medication instructions, pre-procedure preparation guides — directly within the conversation thread.
All messages encrypted with TLS 1.3 in transit and AES-256 at rest. No message content accessible to intermediaries or third parties at any point.
Physician Connect is explicitly excluded from AI analysis. Message content is not processed, summarised, or used for training. Clinical communication remains private and human-only.
Thread access controlled by role-based permissions. Patient-linked threads restricted to clinicians with authorised access. Unauthorised access attempts logged and flagged.
Every message logged with sender identity, recipient identity, timestamp, read receipt, and thread context. Full communication history available for clinical governance review.
Physicians, specialists, and allied health professionals communicating about patient care through secure, documented channels instead of email, WhatsApp, or corridor conversations.
Patients communicating with their clinical team between appointments — medication questions, result queries, symptom updates — through the Patient App without phone calls or reception queues.
Governance teams with visibility into clinical communication patterns, response times, unread message alerts, and compliance with documented communication standards.
Connectivity to global trial registries — ClinicalTrials.gov, EU Clinical Trials Register, and WHO ICTRP. Patient clinical data compared against published eligibility criteria using structured data matching. Ranked match lists generated with inclusion/exclusion criteria assessment. Pre-populated referral letters for eligible trials. No AI inference — structured comparison only.
Every major clinical trial registry queried simultaneously through a single patient-linked search.
When a clinician initiates a trial search for a patient, AXIVIS extracts the patient's structured clinical data — diagnosis, staging, biomarkers, mutation status, prior treatments, performance status, organ function, and demographics — and compares it against the published inclusion and exclusion criteria of all active trials matching the clinical context. Each trial receives a match score based on how many eligibility criteria the patient meets, partially meets, or does not meet. The result is a ranked list of potentially eligible trials, ordered by match strength.
Patient-trial matching in AXIVIS uses structured data comparison against published eligibility criteria. It does not use AI to infer eligibility. Each criterion is evaluated individually against the patient's data — met, partially met, or unmet — with transparent reasoning for each assessment.
Matched trials ranked by criteria coverage (percentage of inclusion criteria met), geographic proximity to the patient's location, trial phase, and recruitment status. Clinicians see the strongest matches first.
Trial matching pulls patient data from across AXIVIS modules — tumour staging from Oncology Intelligence, mutation status from Genomic Intelligence, organ function from Labs & Screening. No manual data entry required.
When a clinician selects a matched trial, AXIVIS displays the full eligibility criteria assessment — each inclusion and exclusion criterion listed alongside the patient's relevant data point, the source of that data (which module, which date, which report), and the assessment result (Met, Partially Met, Unmet). The clinician sees exactly why a trial was matched and which criteria require further evaluation. No black-box matching — every comparison is transparent and verifiable.
Inclusion criteria assessed for coverage. Exclusion criteria assessed for absence. Each criterion linked to the specific data point in the patient record that supports the assessment — traceable from criterion to source document.
Criteria that are met marginally (e.g., haemoglobin 9.8 against a threshold of 9.0) or where the patient data is outdated are flagged as Partial. The clinician determines whether the criterion is clinically met based on current patient status.
For eligible trials, AXIVIS generates a pre-populated referral letter containing patient demographics, diagnosis, key clinical parameters, eligibility assessment summary, and trial site contact details. The clinician reviews and sends.
Patient-trial matching uses structured data comparison against published eligibility criteria. The system does not use AI to predict eligibility, estimate outcomes, or infer clinical suitability beyond the published criteria.
The match list is decision support. The treating clinician determines whether a trial is appropriate based on the full clinical picture, patient preferences, and their own clinical judgement.
Every match assessment is fully transparent — each criterion, each patient data point, and each source document visible. No opaque scoring. No unexplained rankings.
All trial data sourced directly from official registries (ClinicalTrials.gov, EU CTR, WHO ICTRP). Trial status, eligibility criteria, and site information updated from registry feeds.
Oncology teams identifying clinical trial options for patients who have exhausted standard treatment lines or who may benefit from novel therapeutic approaches matched to their molecular profile.
Research coordinators managing trial recruitment, screening eligible patients, and coordinating referrals between treating clinicians and trial sites with pre-populated documentation.
Patients and families accessing information about potentially eligible trials through the Patient Portal, with clear explanations of what each trial involves and how to discuss options with their clinical team.
Every clinical document stored with AES-256 encryption, automatically classified by sensitivity level using NLP, searchable through natural language queries, and governed by role-based access controls with complete audit logging. Unlimited storage per patient. Every access recorded. Every document retrievable.
Clinical documents contain the most sensitive data in healthcare — genomic results, psychiatric assessments, HIV status, substance use records, safeguarding reports. AXIVIS Vault applies a multi-layer security architecture to every stored document. AES-256 encryption at rest, TLS 1.3 in transit, HSM-managed encryption keys, role-based access controls enforced at the document level, and immutable audit logging of every access event. No document is stored unencrypted. No access goes unlogged.
Every document encrypted with AES-256 before storage. Encryption keys managed through Hardware Security Modules (HSM) — keys never exist in plaintext outside the HSM boundary.
All document transfers encrypted with TLS 1.3 with certificate pinning and forward secrecy. No document transmitted in cleartext under any circumstance.
Access permissions enforced at the individual document level, not the folder level. Clinicians see only documents their role authorises. Sharing requires explicit permission grant with audit trail.
When a document enters the Vault, NLP analyses the content and automatically classifies its sensitivity level — High, Medium, or Low. Genomic results, psychiatric assessments, HIV-related records, and safeguarding documents are classified as High sensitivity with restricted access controls. Diagnostic reports and laboratory results are classified as Medium. Administrative correspondence is classified as Low. Classification is based on document content analysis, not file type or folder location — a PDF containing genomic data receives the same High classification as a VCF file.
NLP scans document content for sensitivity markers — genetic identifiers, mental health terminology, substance use references, safeguarding language, sexual health content. Classification assigned based on content, not metadata.
Clinicians search the Vault using natural language queries — "latest genomic report", "blood results from March", "psychiatric assessment PHQ-9". Semantic search returns relevant documents ranked by relevance without requiring exact filename or date knowledge.
No artificial storage limits per patient. Every document — from a single-page consultation letter to a multi-gigabyte whole genome sequencing file — stored without capacity restriction.
Document access in healthcare is as sensitive as the documents themselves. AXIVIS Vault logs every access event — who viewed a document, when, from which device, for how long. Document sharing between clinicians requires explicit permission grant with documented clinical justification. Shared access can be time-limited and revoked. Downloads are logged with the downloading clinician's identity and the clinical context. The complete access history for any document is available for governance review at any time.
Every interaction with a document recorded: views with duration, downloads with destination context, shares with recipient and justification, prints, and exports. No silent access.
Document sharing requires the sharer to specify the recipient, clinical justification, and access duration. Shared access can be revoked at any time. Expired shares become inaccessible automatically.
Patients access their own Vault through the patient portal. They can view documents shared with them, download their own records, and see which clinicians have accessed their documents — full transparency.
AES-256 at rest, TLS 1.3 in transit, HSM key management. Documents are never stored or transmitted in cleartext under any circumstance.
NLP analyses document content and assigns sensitivity level automatically. High-sensitivity documents receive restricted access controls without manual intervention.
Every view, download, share, print, and export logged with clinician identity, timestamp, device, duration, and clinical context. No access goes unrecorded.
Document storage configured to comply with country-level data residency requirements. Genomic and clinical data stored within the jurisdiction specified by the institution.
Physicians, specialists, and allied health professionals storing and retrieving clinical documents with natural language search and role-appropriate access to sensitive patient records.
Patients accessing their own document vault through the patient portal — viewing shared records, downloading personal health data, and monitoring which clinicians have accessed their documents.
Data protection officers and information governance teams monitoring access patterns, sensitivity classification accuracy, sharing compliance, and data residency adherence across the institution.
Real-time multimodal clinical data synthesis with structured risk stratification, prescription safety validation, and referral pathway intelligence. From consultation audio to signed clinical record in under 60 seconds.
Data ingestion, clinical reasoning, and structured output — each layer independent, each layer auditable.
Real-time clinical reasoning from data ingestion to structured output.
The consultation proceeds naturally. AXIVIS captures the full clinical dialogue using medical-grade automatic speech recognition tuned to clinical vocabulary. Speaker differentiation separates clinician from patient. The system structures the transcript into clinical note format in real time — SOAP, discharge summary, referral letter, or institutional custom template. No dictation. No templating. No retrospective documentation.
Clinician and patient dialogue separated automatically. Clinical assertions distinguished from patient-reported symptoms.
AI composes complete clinical documents — not raw transcription but intelligently structured clinical records.
Potential diagnostic terms extracted from transcript and presented for explicit clinician confirmation before entry into record.
Every prescription is validated against the patient's complete medication list, allergy record, renal function, hepatic function, pregnancy status, age, and weight. Drug-drug interactions, duplicate therapy, contraindications, and dose-adjustment requirements are evaluated simultaneously. Critical interactions block prescription completion pending documented clinician override. Advisory alerts inform without interrupting workflow.
High-risk prescribing errors blocked at the system level. Clinician must provide documented clinical rationale to proceed.
If the patient has genomic data in AXIVIS, prescription safety checks include pharmacogenomic interactions affecting drug metabolism and response.
All outputs are decision support. No autonomous diagnosis. No autonomous treatment selection. Clinician review and approval mandatory before record entry or clinical action.
Every output includes a confidence score derived from data completeness, pattern strength, and evidence alignment. Low-confidence outputs trigger explicit uncertainty flags.
Insufficient data for reliable inference triggers refusal — the system withholds output and explicitly flags data gaps rather than generating unreliable guidance.
Every AI inference logged with model version, input-output linkage, reviewing clinician identity, timestamp, and patient record association. Exportable for regulatory submission.
AXIVIS is a Clinical Intelligence Operating System comprised of sixteen modules covering the full diagnostic, clinical, and administrative surface of modern medicine. Every module is fully functional on its own — procurement is à la carte, deployment is 48 hours, integration is HL7 FHIR and DICOM native. Or deploy them together as the unified AXIVIS OS, where modules share a single longitudinal patient record, one Cortex context, and cross-module intelligence flow out of the box.
Every AXIVIS module is a standalone institutional product. The same engineering, the same regulatory positioning, the same EU MDR classification. You can procure one module at a time, or deploy the full OS — the decision is commercial, not technical.
Every card below is deployable as a standalone product or as part of the unified AXIVIS OS. Click any module to see the shipping product and request standalone pricing.
The table below is not a feature-cut — every standalone module is fully functional. The OS adds intelligence propagation between modules. Nothing is hidden behind the OS that isn't in the standalone product.
Whether you deploy one module or all sixteen, these guarantees are invariant. They are commitments of the AXIVIS platform architecture, not premium features.
The commercial decision is yours. The technical architecture supports both. Book a procurement-grade walkthrough with the AXIVIS team and we'll scope the path that fits your institution — single module, phased rollout, or full OS deployment.
AXIVIS delivers medical intelligence infrastructure built for the complexity of real clinical environments — from the independent physician to the enterprise health system.
AXIVIS gives independent physicians the same diagnostic and clinical intelligence infrastructure used by major hospital systems — deployable from a single workspace without institutional IT overhead.
AXIVIS scales with your practice — from a single physician to a multi-specialty group — delivering unified diagnostic, clinical workflow, and patient intelligence without the complexity of enterprise deployment.
Clinical data accessible only to authorised users within the practice. Patient records protected at the appropriate access level for each staff role.
Shared diagnostic orders, patient records, and clinical communication across the full practice in one environment.
Full audit logging of clinical actions, documentation edits, and record access. Compliance infrastructure built in, not added later.
AXIVIS deploys as a unified intelligence layer across hospital departments — integrating diagnostic AI, oncology intelligence, genomic analysis, and clinical workflow tools within existing hospital infrastructure without replacing current systems.
AXIVIS supports diagnostic clinics, specialist centres, imaging facilities, and integrated care organisations with the same AI intelligence layer deployed in major hospital systems.
Deploy AXIVIS infrastructure medicinally across multiple clinical sites with centralised governance and access control.
Patient clinical history accessible across the organisation, with role-based controls ensuring appropriate access at each site and process level.
ISO, SOC 2, HIPAA, and GDPR compliance frameworks applicable across the full organisational deployment.
AXIVIS provides academic medical centres and universities with the clinical intelligence and research data infrastructure needed to advance medical AI research and clinical training programmes.
Patient care data and research data managed within the same infrastructure, with appropriate access controls separating clinical and research functions.
Genomic intelligence, diagnostic data, and clinical records available for translational research activities within the platform's compliance framework.
Compliance and audit infrastructure designed to meet the requirements of academic institutional governance and research ethics frameworks.
AXIVIS collaborates with research institutions and pharmaceutical organisations to build large-scale medical intelligence datasets across oncology, genomics, diagnostics, and precision medicine.
VCF ingestion, variant annotation, pharmacogenomic modelling, and disease-risk infrastructure available for research workflows.
Laboratory and biomarker data tracked longitudinally across patient records, accessible for research analysis within the compliance framework.
Trial matching based on molecular and clinical criteria. Patient identification for potential trial enrolment supported within the platform.
AXIVIS is architected as sixteen standalone modules that also compose into a unified Clinical Intelligence Operating System. You do not have to procure the full OS on day one — start with a single module that addresses your most pressing clinical gap, prove value in 48 hours, and add adjacent modules later without any migration overhead. The standalone module and the OS-deployed module are the same codebase.
Clinical intelligence deployment records from live hospital environments. Each case documents AXIVIS modules, data flows, and outcomes across a specific specialty and patient pathway.
Clinical-grade intelligence applied to your own biology. Every marker tracked. Every pattern surfaced. Every risk detected before symptoms appear.
Preventable chronic disease is detectable years before diagnosis. The biological signals exist in laboratory data, genetic markers, and measurable biomarkers that most people have access to but no system to interpret at clinical depth.
AXIVIS BIO-Score monitors your biological markers continuously as new data is added. Laboratory values, biomarker trends, and genomic risk factors are tracked longitudinally. When a pattern changes, you are informed before it becomes a clinical event.
Individual health data points tell part of a story. A rising inflammatory marker means something different alongside an abnormal imaging finding and a genomic risk factor than it does in isolation. The Diagnostic Intelligence Hub consolidates your complete health data and identifies patterns appearing across multiple data types simultaneously.
The pattern is often more important than the individual result.
Biological age reflects how your body is functioning relative to population norms at the cellular and systemic level. Derived from genomic markers, inflammatory indicators, and metabolic function, AXIVIS Black generates a clinical-grade assessment of biological function.
Genetic test reports and raw sequencing data contain information about disease susceptibility, drug metabolism, and biological resilience. AXIVIS Black ingests your genetic data and generates a structured genetic health summary organized by clinical priority.
AXIVIS Black analyzes your symptoms against your biological profile, health history, genomic data, and existing biomarker trends. The system identifies possible clinical patterns and directs you to the appropriate specialist.
The right specialist, identified from your data. Not from a list.
Mental health is a biological state. PsycheCore provides continuous psychological wellbeing monitoring and AI-assisted support available around the clock, integrated into your complete biological picture.
AXIVIS Black evaluates your complete health and genetic profile against available clinical trials and surfaces studies you may be eligible for. Particularly relevant for individuals managing complex conditions.
AXIVIS Health Vault stores all your records in one encrypted, searchable repository. NLP-based search retrieves any document using clinical language. Sensitivity classification protects the most private records.
When your biological data surfaces findings that require professional evaluation, AXIVIS Black connects you to physicians and clinical services within the platform. Care appointments, physician messaging, and diagnostic orders are all available without leaving the environment where your data lives.
The data informs the consultation. The consultation informs the next action.
Structured biological monitoring, medication tracking, longitudinal data analysis, and clinical trial matching for people who need to understand their health data at the same depth their physician does.
Biological age analysis, genomic risk stratification, continuous biomarker monitoring, and cross-signal pattern detection for individuals who approach health as a long-term scientific discipline.
Physicians and clinical specialists who want the same intelligence layer they apply to patient data applied to their own. Clinical-grade analysis without the clinical context removal.
AXIVIS Black is currently available by request. Access is reviewed to ensure the platform is matched to the right individuals and use cases.
AXIVIS works with NHS trusts, academic medical centres, and international hospital networks to capture, structure, and annotate real-world clinical data at institutional scale. Every diagnostic event, genomic result, and treatment decision recorded through AXIVIS becomes a structured, research-ready intelligence asset — available under a rigorous, tiered governance framework.
Training and validation datasets for supervised and self-supervised learning across imaging, genomics, time-series vitals, and clinical text. Annotated for multi-task learning with clinician-approved ground truth labels at point of care.
Whole-exome and targeted panel VCF datasets linked to longitudinal clinical phenotypes, treatment response, pharmacogenomic profiles, and survival. CPIC-tiered variant annotations for every cohort with tumour-normal pairs for 4,200 solid tumour cases.
Structured cancer pathway records from primary diagnosis through MDT, treatment, response, and survivorship. Population-scale cohorts across 18 tumour types with 7-year median follow-up and linked biobank samples for 6,800 cases.
Multi-modal imaging corpora with radiologist-validated AI annotation overlays, procedural video with frame-level detection labels, and pathology slides linked to molecular classification and outcome data across 12 imaging modalities.
Every clinical interaction on the AXIVIS platform generates structured, annotated, research-ready data. What physicians use to treat patients becomes the intelligence that researchers use to advance medicine. No separate data collection pipeline. No retrospective annotation burden. No institutional silos.
Whole-exome and targeted panel sequencing VCF datasets across oncology, rare disease, and pharmacogenomics cohorts. Every variant annotated at CPIC and ClinVar tier level and linked to longitudinal clinical outcome records. Includes matched tumour-normal pairs for 4,200 solid tumour cases and a pharmacogenomics sub-cohort of 3,100 patients with confirmed adverse drug event records.
Generated through the AXIVIS Clinical Timeline, this dataset captures the entire journey from primary screening and pathology through MDT decision, treatment, response assessment, and long-term survivorship. Structured across 18 tumour types with 7-year median follow-up. Linked biobank samples available for 6,800 cases. MDT decision records include tumour board package content, treatment tier rationale, and clinical trial eligibility scores.
Structural and functional imaging data across 12 modalities with DICOM annotations linked to lab values, genomic findings, and clinical outcomes. Each imaging episode cross-referenced to the full AXIVIS clinical record. Radiologist-validated AI annotation overlays for CT chest (iPE, nodule), CT head (stroke, ASPECTS 0–10), and MRI brain included. Procedure video sub-corpus of 14,000 laparoscopic cases with frame-level anomaly labels.
Anonymised summary statistics, model benchmarks, and validation metrics. Available without application for academic and commercial researchers.
Individual-level anonymised datasets for non-commercial academic research. Application-based with 4-week review by the Research Access Committee.
Complete longitudinal cohorts including genomics, cancer pathways, and multi-modal imaging with clinical correlation. For NHS and academic institutions.
For commercial AI developers and pharmaceutical research divisions. Includes NLP datasets, proprietary annotation layers, and full API pipeline access.
NHS trusts, private hospital groups, and specialist centres contribute anonymised clinical data under the AXIVIS Data Contribution Agreement. All governance managed within existing NHS IG and GDPR frameworks — no additional infrastructure required. Contribution partners receive access credit towards higher research tiers.
University hospitals and academic departments contribute annotated research cohorts and participate in validation studies. Academic collaborators receive priority access to derived datasets, model benchmarks, and co-authorship rights on publications arising from contributed data under a structured Academic Collaboration Agreement.
Independent research institutes, biobanks, and pharmaceutical research divisions contribute validated datasets under a Data Transfer Agreement. All contributions are version-controlled and attribution-tracked within the governance audit trail. Biobank linkage is available for genomic cohort contributions meeting minimum size criteria of 500 patients.
All AXIVIS research data collection operates under a single harmonised NHS Health Research Authority-approved protocol (REC ref: 25/NW/0142). Data processing activities are registered with the ICO under the AXIVIS Data Controller registration. All international data transfers comply with GDPR Chapter V adequacy and Standard Contractual Clauses requirements. The AXIVIS research programme holds MHRA Software as a Medical Device registration under the UK Medical Devices Regulations 2002.
AXIVIS applies a three-stage de-identification pipeline: (1) automated PHI extraction using NLP entity recognition across all structured and unstructured fields; (2) quasi-identifier risk scoring using k-anonymity (k≥10) and l-diversity metrics per dataset release; (3) independent expert determination audit for all cohorts with cell counts below threshold. Full methodology is published in the AXIVIS Data Governance Specification v3.2, available on request.
AXIVIS operates a standing Patient and Public Involvement panel that reviews the research use framework annually and contributes to consent language and access policy design. All data use notifications are published in plain-language summaries accessible through the contributing hospital trust's patient portal. Patients retain the right to opt out of research data use at any time through the NHS Type 1 opt-out mechanism.
Every research data access event is logged in the AXIVIS Research Governance Ledger with full provenance: which dataset was accessed, by which institution, under which agreement, and for which stated research purpose. Annual audit reports are published publicly on the AXIVIS Research website. All access agreements include mandatory six-month reporting obligations and data destruction certificates on expiry, independently verified by the AXIVIS Data Protection Officer.
Advancing the science behind clinical AI reasoning.
Structured, annotated datasets from real clinical practice.
Clinical trial infrastructure powered by real-world intelligence.
AXIVIS AI is a Medical AI and Clinical Research platform developed under Arenberg AG, a Swiss technology company headquartered in Zug, Switzerland.
AXIVIS AI is a Medical AI and Clinical Research platform built to transform fragmented diagnostic, genomic, and clinical data into real-time medical intelligence used by hospitals, physicians, research institutions, and individuals through AXIVIS Black.
AXIVIS AI operates as a dedicated Medical AI and Research Technology division under Arenberg AG, with its own clinical governance, compliance framework, and AI development infrastructure.
To accelerate the transition to proactive, intelligence-driven medicine by building the world's most advanced medical AI infrastructure.
A future where clinical intelligence is ubiquitous, enabling every physician to deliver personalised, preventative, and precise care to every patient, globally.
Clinical data in modern medicine is highly advanced but fragmented across imaging systems, laboratory platforms, genomic databases, and clinical records. These systems operate in isolation, forcing clinicians to make decisions from incomplete information while large volumes of patient data remain unused.
Even when data exists, it is not accessible in a usable form. Clinicians are required to interpret multiple disconnected outputs across systems, often under time constraints. The issue is not lack of data, but lack of integrated intelligence.
The solution is not another standalone tool. It is a unified intelligence layer capable of ingesting multiple data types and delivering structured outputs directly within existing clinical workflows.
AXIVIS AI operates as a unified platform across diagnostics, oncology, genomics, and clinical workflows, serving physicians, hospitals, research institutions, and individuals through AXIVIS Black.
We build medical intelligence infrastructure, not general purpose software. Every system is designed around a specific clinical problem, grounded in how physicians actually work across diagnostics, oncology, and genomics.
Our approach combines clinical research, real-world data, and AI engineering with strict standards for safety, traceability, and human oversight. Every output is structured, explainable, and designed to support clinical decision making, not replace it.
Medical AI and clinical research infrastructure built for institutional deployment.
AXIVIS is not a general-purpose AI tool. Every module is built around a specific clinical workflow — radiology triage, oncology pathway management, genomic variant interpretation, ICU surveillance — and is designed to operate within existing hospital infrastructure without requiring new hardware, separate login systems, or parallel documentation processes.
The platform ingests multimodal clinical data — DICOM imaging, genomic VCF files, laboratory results, procedure video, telehealth transcripts — and returns structured, clinician-reviewable intelligence outputs. No black boxes. No autonomous decisions. Every finding is traceable, auditable, and assigned to the responsible clinician.
Designed around how physicians actually work, not around what data science can produce.
Clinician review is required for every AI output. No autonomous clinical decisions.
Trained and validated on prospective clinical data, not curated academic benchmarks.
NHS IG, GDPR, MHRA, and ISO-compliant. Built for enterprise healthcare environments.
AXIVIS is shaped by clinical experience, technical depth, and real-world medical workflows. Every feature is designed to support accurate and fast decision making in complex environments.
Our clinical science team includes practising physicians from oncology, radiology, genomics, and emergency medicine who validate every module in real clinical environments before deployment.
Our AI and machine learning engineers specialise in medical imaging, genomic data processing, and clinical NLP. Every model is built to clinical-grade explainability and safety standards.
Our governance team maintains NHS IG, GDPR, and MHRA compliance across all product lines and research activities, with dedicated clinical safety officers for each platform deployment.
A Swiss-based investment and development firm focused on advanced AI systems across healthcare, finance, and strategic intelligence.
AXIVIS AI is a core initiative of Arenberg AG, a Swiss-based investment and development firm focused on advanced AI systems across healthcare, finance, and strategic intelligence.
This stewardship ensures long-term stability, rigorous ethical standards, and a commitment to clinical excellence that transcends typical venture-backed cycles. Arenberg AG provides the governance infrastructure, capital stability, and institutional credibility that healthcare deployments require.
Arenberg AG is headquartered in Zug, Switzerland — a jurisdiction recognised for its rigorous financial regulation, data protection law, and technology governance standards, making it the natural home for a platform operating at the intersection of medical AI and institutional data.
VISIT ARENBERG AG ↗Arenberg AG provides patient, long-horizon capital that insulates AXIVIS from short-term commercial pressures. Clinical AI requires years of validation, regulatory approval, and real-world refinement before it is ready for institutional scale.
Arenberg AG's Swiss incorporation brings rigorous governance frameworks, FINMA-adjacent regulatory discipline, and data protection standards aligned with Swiss-EU adequacy requirements — all of which flow through to AXIVIS AI's operational structure.
Arenberg AG's portfolio spans healthcare, finance, and strategic intelligence. This cross-sector perspective informs AXIVIS's approach to building infrastructure that meets the standards of regulated industries, not just healthcare software norms.
AXIVIS AI operates with independent board-level oversight through Arenberg AG, ensuring that product direction, clinical safety decisions, and research ethics are reviewed by a body with no short-term commercial incentive to accelerate beyond safe boundaries.
Whether you are a health system leader, a clinical specialist, or a potential partner, we'd love to hear from you.
Existing customers can access technical support and documentation through the AXIVIS Support Portal.
Rigorous independent auditing of security, availability, processing integrity, confidentiality, and privacy controls. Audited annually by a PCAOB-registered firm.
COMPLIANTStandard enterprise deployment with full compliance framework. Multi-tenant architecture with complete data isolation between institutions.
Dedicated infrastructure for institutions with data residency requirements. Single-tenant deployment on Swiss or EU-only infrastructure.
Full on-premise deployment for institutions with data sovereignty requirements. Full platform capability with local compute and storage.
Patient data protection is not a compliance requirement for AXIVIS AI. It is a design principle.
Every system is built with privacy by design — data is encrypted, access is role-based, and every action on patient data is logged in a full audit trail.
Need compliance documentation
or have security questions?
Tell us about your practice or institution. We will configure the demonstration around your specific clinical workflows and data environment.